drugset / Trial / NCT01022047

Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis

NCT01022047 ↗

Phase 3 Completed 280 enrolled Eurofarma Laboratorios S.A.
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the efficacy of the study product Noex in the treatment of allergic rhinitis by means of the Nasal Index Score (NIS) after 4 weeks of treatment with the drug.

Timeline

Start
2010-02
Primary completion
2010-02
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budecort Aqua Unknown 32 ug Intranasal
Subject Noex Unknown 32 ug Intranasal

Indications